{
    "2018-03-08": [
        [
            {
                "time": "2018-03-08",
                "original_text": "M&A, Innovation & New Drugs to Drive Pharma Stocks",
                "features": {
                    "keywords": [
                        "M&A",
                        "Innovation",
                        "New Drugs",
                        "Pharma Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Want to be a Buy and Hold Investor? 3 Strategies",
                "features": {
                    "keywords": [
                        "Buy",
                        "Hold",
                        "Investor",
                        "Strategies"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Biotech Stock Round Up: Regeneron Submits sBLA, Biogen to Withdraw Zinbryta",
                "features": {
                    "keywords": [
                        "Biotech Stock",
                        "Regeneron",
                        "sBLA",
                        "Biogen",
                        "Withdraw",
                        "Zinbryta"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Multimillion-dollar drug yanked from market connected to dangerous brain inflammation cases in U.S.",
                "features": {
                    "keywords": [
                        "drug",
                        "yanked",
                        "market",
                        "brain inflammation",
                        "U.S."
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Key Updates on BMYâ€™s Reyataz and Hepatitis C Franchise",
                "features": {
                    "keywords": [
                        "BMY",
                        "Reyataz",
                        "Hepatitis C",
                        "Franchise"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-08",
                "original_text": "Validea John Neff Strategy Daily Upgrade Report - 3/8/2018",
                "features": {
                    "keywords": [
                        "Validea",
                        "John Neff",
                        "Strategy",
                        "Daily Upgrade Report"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}